- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ALPHA TAU MEDICAL Aktie jetzt für 0€ handeln | |||||
| Di | H.C. Wainwright reiterates Alpha Tau Medical stock rating on trial enrollment | 2 | Investing.com | ||
| Mo | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 11 | SEC Filings | ||
| 12.08. | H.C. Wainwright raises Alpha Tau Medical stock price target to $16 | 1 | Investing.com | ||
| 12.08. | H.C. Wainwright hebt Kursziel für Alpha Tau Medical auf 16 $ an | 3 | Investing.com Deutsch | ||
| 10.08. | Alpha Tau Medical GAAP EPS of -$0.25 | 1 | Seeking Alpha | ||
| 10.08. | Alpha Tau Medical Ltd.: Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update | 290 | GlobeNewswire (Europe) | - Groundbreaking interim results from the U.S. recurrent glioblastoma REGAIN trial demonstrated 100% local disease control and a 67% complete response rate, followed by FDA clearance to complete trial... ► Artikel lesen | |
| 10.08. | Alpha Tau plans dual listing on Nasdaq and TASE to expand access for Israeli investors | 3 | Seeking Alpha | ||
| 10.08. | Alpha Tau Medical Ltd.: Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) | 1 | GlobeNewswire (USA) | ||
| 10.08. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.07. | H.C. Wainwright reiterates Alpha Tau Medical stock rating at buy | 1 | Investing.com | ||
| 21.07. | Alpha Tau rises on Alpha DaRT head and neck cancer data | 5 | Seeking Alpha | ||
| 21.07. | Alpha Tau reports positive trial results for cancer therapy combo | 4 | Investing.com | ||
| 21.07. | Alpha Tau meldet positive Studienergebnisse für kombinierte Krebstherapie | 1 | Investing.com Deutsch | ||
| 21.07. | Alpha Tau Medical Ltd.: Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, ... | 296 | GlobeNewswire (Europe) | - Podium presentation at the American Head and Neck Society (AHNS) 12th International Conference on Head and Neck Cancer to report results from a study of Alpha DaRT in combination with pembrolizumab... ► Artikel lesen | |
| 17.07. | H.C. Wainwright reiterates Alpha Tau Medical stock rating on immunocompromised patient treatment | 1 | Investing.com | ||
| 17.07. | H.C. Wainwright bestätigt Rating für Alpha Tau Medical nach Behandlungserfolg bei immunsupprimierten Patienten | 2 | Investing.com Deutsch | ||
| 15.07. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Immunocompromised Patient with Recurrent Cutaneous Squamous Cell Carcinoma in its ADMIRE Study at Banner MD Anderson Cancer Center | 257 | GlobeNewswire (Europe) | - The ADMIRE study, by treating immunocompromised patients, builds on the momentum of Alpha Tau's ReSTART pivotal trial for recurrent cSCC, which recently completed patient enrollment, under which... ► Artikel lesen | |
| 15.07. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.06. | Alpha Tau Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 23.06. | Alpha Tau Medical Ltd.: Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT at Hadassah University Medical Center in Israel | 427 | GlobeNewswire (Europe) | - First glioblastoma patient ever treated with Alpha DaRT® outside of the United States, and the first in Israel - performed at Hadassah University Medical Center in Jerusalem, one of the world's... ► Artikel lesen |
1 2 3 4 Weiter >>
69 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,160 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| BUTTERFLY NETWORK | 6,288 | +0,22 % | Butterfly Network licenses ultrasound tech to Merge Labs for BCI | ||
| BEYOND AIR | 3,580 | -0,28 % | Beyond Air Receives FDA Breakthrough Device Designation for LungFit GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) | GARDEN CITY, N.Y., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| AETHLON MEDICAL | 1,930 | 0,00 % | AETHLON MEDICAL INC - 8-K, Current Report | ||
| HYDREIGHT TECHNOLOGIES | 2,335 | +0,43 % | Hydreight Technologies Inc.: Hydreight Reports Record Q2 2026 Revenue of $28.0 Million, Net Income of $2.5 Million and Adjusted EBITDA of $3.2 Million | Revenue increased 421% year-over-year as Hydreight delivered its strongest revenue quarter to date, with continued sequential growth in revenue and gross profit... ► Artikel lesen | |
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 19,160 | -1,59 % | Tactile Systems Technology, Inc.: Tactile Medical Enters Exclusive U.S. Distribution Agreement with ElastiMed for its MyoSleeve Wearable Compression Device for VA and DoD Patients | MINNEAPOLIS, July 13, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| ANGIODYNAMICS | 13,000 | -2,26 % | Biotech Stocks At 52-Week Highs - Cumberland Pharmaceuticals, Maravai LifeSciences, AngioDynamics, Acadia Healthcare, Teladoc Health | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen | |
| APYX MEDICAL | 2,660 | +1,53 % | Apyx Medical Corporation Reports Second Quarter 2026 Financial Results | Reported total revenue of $13.9 million in the second quarter of 2026 primarily driven by 28% growth in the Surgical Aesthetics segmentSuccessful limited launch of the power liposuction handpiece... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,735 | +0,17 % | Anteris Technologies Global Corp.: Anteris Technologies Announces Results for the Second Quarter of 2026 | MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR) a global healthcare company committed... ► Artikel lesen | |
| ADAPTHEALTH | 6,445 | +0,39 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVITA MEDICAL | 9,200 | -1,08 % | AVITA Medical Reports First Quarter 2026 Financial Results | VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 4,680 | 0,00 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 0,844 | -0,61 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony IL-6 Toward Regulatory Submission and Commercialization | SYMON-II pivotal clinical study completes targeted enrollment of 750 patientsCompany advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate... ► Artikel lesen | |
| AGAPE ATP | 2,390 | 0,00 % | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |
ALPHA TAU MEDICAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 14,620 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ALPHA TAU MEDICAL LTD finden Sie auf Wallstreet Online.